← Back to results

Posted · PAR-27-083

NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)

National Institutes of Health  ·  HHS

CFDA Numbers

93.855

Award Ceiling

Award Floor

Expected Awards

2

Close Date

May 25, 2029

Section I

How to Apply

View on grants_gov ↗

Program Contact

National Institute of Allergy and Infectious Diseases (NIAID)<br/>NIAID_R24_NOFO@mail.nih.gov
NIAID_R24_NOFO@mail.nih.gov

Section II

Eligibility

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Eligible Applicant Types

00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 25

Section III

Description

This notice of funding opportunity (NOFO) invites applications for investigator-initiated Resource-Related Research Projects (R24). The proposed resource must provide a significant benefit to currently funded high priority projects in need of further coordination and support in the areas specified. This mechanism may also be used to support development of a new resource to the broader scientific community of the National Institute of Allergy and Infectious Diseases (NIAID). It is anticipated that the request for resource support through the R24 activity code will occur on an infrequent basis and only in circumstances where other mechanisms of support from the NIAID are not appropriate.The proposed resources should be relevant to the scientific areas of the NIAID mission including the biology, pathogenesis, and host response to microbes, including HIV; the mechanisms of normal immune function and immune dysfunction resulting in autoimmunity, immunodeficiency, allergy, asthma, and transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat infectious, immune-mediated, and allergic diseases.

Section IV

Key Dates

Posted
May 7, 2026
Closes
May 25, 2029
Archive
Jul 24, 2029